Vertex Pharmaceuticals Inc / Ma

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/8/2026

Shares

81,246

Value ($000)

38,075

Weight

0.1%

2020 Q2 - 2025 Q4 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/8/2026	38,075	0.1%	81,246	12/31/2025
2025 Q3	10/29/2025	30,143	0.0%	73,469	9/30/2025
2025 Q2	7/10/2025	37,984	0.1%	82,641	6/30/2025
2025 Q1	4/16/2025	38,878	0.1%	80,189	3/31/2025
2024 Q4	3/17/2025	32,292	0.1%	80,189	12/31/2024
2024 Q3	10/24/2024	47,388	0.1%	101,891	9/30/2024
2024 Q2	7/16/2024	40,128	0.1%	85,612	6/30/2024
2024 Q1	4/15/2024	34,292	0.1%	82,036	3/31/2024
2023 Q4	1/30/2024	30,506	0.1%	74,975	12/31/2023
2023 Q3	11/13/2023	16,549	0.1%	47,589	9/30/2023
2023 Q2	7/21/2023	3,488	0.0%	9,912	6/30/2023
2023 Q1	4/25/2023	3,081	0.0%	9,778	3/31/2023
2022 Q4	2/1/2023	3,102	0.0%	9,694	12/31/2022
2022 Q3	10/17/2022	3,903	0.1%	13,219	9/30/2022
2022 Q1	4/18/2022	6,146	0.1%	22,874	3/31/2022
2021 Q4	2/8/2022	5,366	0.1%	22,043	12/31/2021
2020 Q3	11/12/2020	1,900	0.0%	6,920	9/30/2020
2020 Q2	10/13/2020	3,631	0.1%	12,467	6/30/2020